Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Synthetic Biology Market, by Application
1.4.2 LAMEA Synthetic Biology Market, by End-use
1.4.3 LAMEA Synthetic Biology Market, by Product
1.4.4 LAMEA Synthetic Biology Market, by Technology
1.4.5 LAMEA Synthetic Biology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. LAMEA Synthetic Biology Market by Application
4.1 LAMEA Healthcare Market by Country
4.2 LAMEA Non-healthcare Market by Country
Chapter 5. LAMEA Synthetic Biology Market by End-use
5.1 LAMEA Biotechnology and Pharmaceutical Companies Market by Country
5.2 LAMEA Academic and Government Research Institutes Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Synthetic Biology Market by Product
6.1 LAMEA Oligonucleotide/Oligo Pools and Synthetic DNA Market by Country
6.2 LAMEA Enzymes Market by Country
6.3 LAMEA Cloning Technologies Kits Market by Country
6.4 LAMEA Xeno-Nucleic Acids Market by Country
6.5 LAMEA Chassis Organism Market by Country
Chapter 7. LAMEA Synthetic Biology Market by Technology
7.1 LAMEA PCR Technology Market by Country
7.2 LAMEA NGS Technology Market by Country
7.3 LAMEA Genome Editing Technology Market by Country
7.4 LAMEA Bioprocessing Technology Market by Country
7.5 LAMEA Others Market by Country
Chapter 8. LAMEA Synthetic Biology Market by Country
8.1 Brazil Synthetic Biology Market
8.1.1 Brazil Synthetic Biology Market by Application
8.1.2 Brazil Synthetic Biology Market by End-use
8.1.3 Brazil Synthetic Biology Market by Product
8.1.4 Brazil Synthetic Biology Market by Technology
8.2 Argentina Synthetic Biology Market
8.2.1 Argentina Synthetic Biology Market by Application
8.2.2 Argentina Synthetic Biology Market by End-use
8.2.3 Argentina Synthetic Biology Market by Product
8.2.4 Argentina Synthetic Biology Market by Technology
8.3 UAE Synthetic Biology Market
8.3.1 UAE Synthetic Biology Market by Application
8.3.2 UAE Synthetic Biology Market by End-use
8.3.3 UAE Synthetic Biology Market by Product
8.3.4 UAE Synthetic Biology Market by Technology
8.4 Saudi Arabia Synthetic Biology Market
8.4.1 Saudi Arabia Synthetic Biology Market by Application
8.4.2 Saudi Arabia Synthetic Biology Market by End-use
8.4.3 Saudi Arabia Synthetic Biology Market by Product
8.4.4 Saudi Arabia Synthetic Biology Market by Technology
8.5 South Africa Synthetic Biology Market
8.5.1 South Africa Synthetic Biology Market by Application
8.5.2 South Africa Synthetic Biology Market by End-use
8.5.3 South Africa Synthetic Biology Market by Product
8.5.4 South Africa Synthetic Biology Market by Technology
8.6 Nigeria Synthetic Biology Market
8.6.1 Nigeria Synthetic Biology Market by Application
8.6.2 Nigeria Synthetic Biology Market by End-use
8.6.3 Nigeria Synthetic Biology Market by Product
8.6.4 Nigeria Synthetic Biology Market by Technology
8.7 Rest of LAMEA Synthetic Biology Market
8.7.1 Rest of LAMEA Synthetic Biology Market by Application
8.7.2 Rest of LAMEA Synthetic Biology Market by End-use
8.7.3 Rest of LAMEA Synthetic Biology Market by Product
8.7.4 Rest of LAMEA Synthetic Biology Market by Technology
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Geographical Expansions:
9.1.6 SWOT Analysis
9.2 Genscript Biotech Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional & Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Geographical Expansions:
9.2.6 SWOT Analysis
9.3 DNA TwoPointO Inc. (Atum)
9.3.1 Company Overview
9.4 Integrated DNA Technologies, Inc. (Danaher Corporation)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.6 SWOT Analysis
9.5 Eurofins Scientific SE
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 SWOT Analysis
9.6 OriGene Technologies, Inc.
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Twist Bioscience Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Product Launches and Product Expansions:
9.7.6 SWOT Analysis
9.8 Editas Medicine, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Research & Development Expenses
9.8.4 SWOT Analysis
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Merck KGaA
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 SWOT Analysis
Unique Offerings 